03:25:14 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



News for U:ERNA from 2023-05-03 to 2024-05-02 - 12 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-02-20 08:30U:ERNANews ReleaseEterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
2024-01-03 16:15U:ERNANews ReleaseEterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
2023-12-20 16:16U:ERNANews ReleaseEterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer
2023-12-14 18:56U:ERNANews ReleaseEterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing
2023-11-01 08:30U:ERNANews ReleaseEterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors
2023-09-06 08:00U:ERNANews ReleaseEterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics
2023-09-05 08:31U:ERNANews ReleaseEterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
2023-07-18 08:00U:ERNANews ReleaseEterna Therapeutics Announces Completion of $8.7 Million of Convertible Debt Financing
2023-07-11 08:30U:ERNANews ReleaseEterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors
2023-05-24 08:30U:ERNANews ReleaseEterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel
2023-05-17 08:31U:ERNANews ReleaseEterna Therapeutics and Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
2023-05-04 08:30U:ERNANews ReleaseEterna Therapeutics to Deliver Eight Presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting